Vanguard Portfolio Management’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$64.1M Buy
3,939,768
+196,675
+5% +$3.4M ﹤0.01% 1628
2026
Q2
$67.2M Buy
3,743,093
+56,456
+2% +$790K ﹤0.01% 1628
2026
Q1
$34.7M Buy
+3,686,637
New +$40.5M ﹤0.01% 1759

Other funds holding IART

Vanguard Portfolio Management's IART Position: Q3 2026 in Review

Vanguard Portfolio Management increased its Integra LifeSciences (IART) stake by 5.3% in Q3 2026, buying an estimated $3.4M and bringing the position to 3,939,768 shares worth $64.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1628.

Vanguard Portfolio Management first reported a position in IART in Q1 2026 and has held it in 3 quarters since. The position peaked at $67.2M in Q2 2026. 234 funds tracked by Wall St. Rank hold IART as of Q3 2026.

  • Vanguard Portfolio Management held 3,939,768 shares of Integra LifeSciences worth $64.1M as of Q3 2026.
  • Vanguard Portfolio Management bought 196,675 Integra LifeSciences shares in Q3 2026, an estimated $3.4M.
  • Integra LifeSciences made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1628 holding.
  • Vanguard Portfolio Management first reported a position in Integra LifeSciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Portfolio Management's Integra LifeSciences position peaked at $67.2M in Q2 2026.
  • 234 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.